A detailed history of Sentry Investment Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sentry Investment Management LLC holds 9,341 shares of BMY stock, worth $496,847. This represents 0.17% of its overall portfolio holdings.

Number of Shares
9,341
Previous 10,954 14.73%
Holding current value
$496,847
Previous $594,000 34.68%
% of portfolio
0.17%
Previous 0.23%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$40.25 - $52.99 $64,923 - $85,472
-1,613 Reduced 14.73%
9,341 $388,000
Q4 2023

Jan 30, 2024

SELL
$48.48 - $57.85 $57,060 - $68,089
-1,177 Reduced 9.7%
10,954 $562,000
Q3 2023

Nov 03, 2023

SELL
$57.89 - $64.73 $159,892 - $178,784
-2,762 Reduced 18.55%
12,131 $704,000
Q1 2023

Apr 26, 2023

BUY
$65.71 - $74.53 $5,059 - $5,738
77 Added 0.52%
14,893 $1.03 Million
Q4 2022

Feb 08, 2023

BUY
$68.48 - $81.09 $21,845 - $25,867
319 Added 2.2%
14,816 $1.07 Million
Q3 2022

Nov 01, 2022

SELL
$0.13 - $76.84 $105 - $62,163
-809 Reduced 5.29%
14,497 $1.03 Million
Q2 2022

Aug 02, 2022

SELL
$72.62 - $79.98 $251,265 - $276,730
-3,460 Reduced 18.44%
15,306 $1.18 Million
Q1 2022

May 09, 2022

SELL
$61.48 - $73.72 $183,886 - $220,496
-2,991 Reduced 13.75%
18,766 $1.37 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $160,353 - $186,934
2,990 Added 15.93%
21,757 $1.36 Million
Q3 2021

Nov 03, 2021

SELL
$59.17 - $69.31 $317,802 - $372,264
-5,371 Reduced 22.25%
18,767 $1.11 Million
Q1 2021

Apr 21, 2021

SELL
$59.34 - $66.74 $6.79 Million - $7.64 Million
-114,485 Reduced 82.59%
24,138 $1.52 Million
Q4 2020

Feb 02, 2021

SELL
$57.74 - $65.43 $155,667 - $176,399
-2,696 Reduced 1.91%
138,623 $8.6 Million
Q3 2020

Nov 05, 2020

BUY
$57.43 - $63.64 $284,106 - $314,827
4,947 Added 3.63%
141,319 $8.52 Million
Q2 2020

Aug 07, 2020

SELL
$54.82 - $64.09 $712,934 - $833,490
-13,005 Reduced 8.71%
136,372 $8.02 Million
Q1 2020

May 05, 2020

BUY
$46.4 - $67.43 $173,164 - $251,648
3,732 Added 2.56%
149,377 $8.33 Million
Q4 2019

Feb 06, 2020

BUY
$49.21 - $64.19 $2.12 Million - $2.76 Million
43,016 Added 41.91%
145,645 $9.35 Million
Q3 2019

Nov 08, 2019

BUY
$42.77 - $50.71 $621,234 - $736,562
14,525 Added 16.49%
102,629 $5.2 Million
Q2 2019

Aug 12, 2019

SELL
$44.62 - $49.34 $444,504 - $491,525
-9,962 Reduced 10.16%
88,104 $4 Million
Q1 2019

May 08, 2019

SELL
$45.12 - $53.8 $390,107 - $465,154
-8,646 Reduced 8.1%
98,066 $4.68 Million
Q4 2018

Feb 11, 2019

SELL
$48.76 - $63.23 $134,480 - $174,388
-2,758 Reduced 2.52%
106,712 $5.55 Million
Q3 2018

Nov 06, 2018

BUY
$55.19 - $62.25 $51,933 - $58,577
941 Added 0.87%
109,470 $6.8 Million
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $606,713 - $756,200
-12,007 Reduced 9.96%
108,529 $6.01 Million
Q1 2018

May 02, 2018

SELL
$59.92 - $68.98 $682,668 - $785,889
-11,393 Reduced 8.64%
120,536 $7.62 Million
Q4 2017

Feb 07, 2018

SELL
$59.94 - $65.35 $3,116 - $3,398
-52 Reduced 0.04%
131,929 $8.09 Million
Q3 2017

Nov 13, 2017

SELL
$55.23 - $63.74 $4,805 - $5,545
-87 Reduced 0.07%
131,981 $8.41 Million
Q2 2017

Aug 21, 2017

BUY
N/A
132,068
132,068 $7.36 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sentry Investment Management LLC Portfolio

Follow Sentry Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentry Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentry Investment Management LLC with notifications on news.